137 related articles for article (PubMed ID: 37951143)
1. Generation and characterization of induced pluripotent stem cells from breast cancer patients carrying ATM mutations.
Zhang M; Venkateshappa R; Li A; Fowler MB; Telli ML; Wu JC
Stem Cell Res; 2023 Dec; 73():103246. PubMed ID: 37951143
[TBL] [Abstract][Full Text] [Related]
2. Generation of human induced pluripotent stem cell lines carrying heterozygous PLN mutation from dilated cardiomyopathy patients.
Caudal A; Mondejar-Parreño G; Vera CD; Williams DR; Shenoy SP; Liang D; Wu JC
Stem Cell Res; 2022 Aug; 63():102855. PubMed ID: 35853412
[TBL] [Abstract][Full Text] [Related]
3. Generation of induced Pluripotent Stem Cells (UNIBSi008-A, UNIBSi008-B, UNIBSi008-C) from an Ataxia-Telangiectasia (AT) patient carrying a novel homozygous deletion in ATM gene.
Masneri S; Ferraro RM; Lanzi G; Piovani G; Mori L; Barisani C; Moratto D; Plebani A; Badolato R; Soresina A; Giliani S
Stem Cell Res; 2019 Dec; 41():101596. PubMed ID: 31669783
[TBL] [Abstract][Full Text] [Related]
4. Generation of an induced pluripotent stem cell line (SDASi001-A) from a Schimke immune-osseous dysplasia patient with SMARCAL1 mutations.
Wang X; Zhang H; Wang X; Zhou W; Dong L; Li N; He Q
Stem Cell Res; 2023 Oct; 72():103217. PubMed ID: 37788557
[TBL] [Abstract][Full Text] [Related]
5. Characterization of human induced pluripotent stem cells line (PNUSCRi004-A) from a Parkinson's disease patient carrying L483P, A495P and V499V mutations.
Moon HJ; Lee N; Moon JY; Lee JH; Kim JH
Stem Cell Res; 2023 Apr; 68():103051. PubMed ID: 36805467
[TBL] [Abstract][Full Text] [Related]
6. Generation of an induced pluripotent stem cell lines HMSCASTi002-A from peripheral blood mononuclear cells of a 38-year-old healthy female individual.
Xian X; Liu J; Zhang J; Hao P; Zhai Y; Cheng J; Yue F; Ma M; Zhang Z; Luan F; Ren Q
Stem Cell Res; 2022 Oct; 64():102907. PubMed ID: 36099765
[TBL] [Abstract][Full Text] [Related]
7. Generation of a human iPSC line (CHCMUi002-A) from peripheral blood mononuclear cells from a chronic granulomatous disease patient.
Zeng A; Ni K; Fang S; Yu L; Gao Y; Zhou L; Zhao X
Stem Cell Res; 2024 Feb; 74():103269. PubMed ID: 38134578
[TBL] [Abstract][Full Text] [Related]
8. Generation of human induced pluripotent stem cell (iPSC) lines derived from five patients carrying the pathogenic phospholamban-R14del (PLN-R14del) variant and three non-carrier family members.
Mittal N; Dave J; Harakalova M; van Tintelen JP; Asselbergs FW; Doevendans PA; Costa KD; Turnbull IC; Stillitano F
Stem Cell Res; 2022 Apr; 60():102737. PubMed ID: 35247838
[TBL] [Abstract][Full Text] [Related]
9. An integration-free iPSC line ZZUNEUi029-A derived from peripheral blood mononuclear cells of a patient with familial hypercholesterolemia carrying a mutation in LDLR gene.
Zhu K; Zhao J; Qin F; Chen X; Xu H; Li X; Tao H
Stem Cell Res; 2023 Sep; 71():103182. PubMed ID: 37586167
[TBL] [Abstract][Full Text] [Related]
10. Generation of two induced pluripotent stem cell lines from breast cancer patients carrying BRCA2 variants.
Zhang M; Liu W; Li A; Htet MH; Yu R; Telli ML; Wu JC
Stem Cell Res; 2023 Oct; 72():103219. PubMed ID: 37816281
[TBL] [Abstract][Full Text] [Related]
11. Generation of a human induced pluripotent stem cell line (JSPHi003-A) from a patient with atrial fibrillation and ventricular tachycardia carrying LMNA frame shift mutation (c.1304_1307dup).
Lin Z; Cheng H; Zhang Y; Zheng B; Zhang F; Lin Y; Zhu Y; Ju W; Cui C; Chen M
Stem Cell Res; 2022 Oct; 64():102909. PubMed ID: 36095892
[TBL] [Abstract][Full Text] [Related]
12. An induced pluripotent stem cell line (YCMi006-A) generated from a patient with hypertrophic cardiomyopathy who carries the ACTA1 mutation p.Ile343Met.
Kim H; Kim HJ; Oh J; Lee ST; Won D; Choi HK; Choi JR; Kim S; Kim HP; Kim SJ; Park SW; Kang SM; Lee SH
Stem Cell Res; 2022 Aug; 63():102874. PubMed ID: 35917599
[TBL] [Abstract][Full Text] [Related]
13. Generation of three induced pluripotent stem cell lines (SCVIi014-A, SCVIi015-A, and SCVIi016-A) from patients with LQT1 caused by heterozygous mutations in the KCNQ1 gene.
Zhang H; Jahng JWS; Liu Y; Chase AJ; Perez MV; Wu JC
Stem Cell Res; 2021 Aug; 55():102492. PubMed ID: 34411974
[TBL] [Abstract][Full Text] [Related]
14. Ataxia Telangiectasia iPSC line generated from a patient olfactory biopsy identifies novel disease-causing mutations.
Leeson HC; Hunter Z; Chaggar HK; Lavin MF; Mackay-Sim A; Wolvetang EJ
Stem Cell Res; 2021 Oct; 56():102528. PubMed ID: 34507142
[TBL] [Abstract][Full Text] [Related]
15. Generation of four gene-edited human induced pluripotent stem cell lines with mutations in the ATM gene to model Ataxia-Telangiectasia.
Nurieva W; Ivanova E; Chehab S; Singh P; Reichlmeir M; Szuhai K; Auburger GWJ; Skarnes WC; Ivics Z
Stem Cell Res; 2023 Dec; 73():103247. PubMed ID: 37976651
[TBL] [Abstract][Full Text] [Related]
16. Generation of induced pluripotent stem cell line (XWHNi002-A) from a female with APP gene mutation.
Sun W; Wang P; Gong J; Chen Y; Yang Y; Luan H; Li S; Li R; Wei C
Stem Cell Res; 2023 Sep; 71():103149. PubMed ID: 37356183
[TBL] [Abstract][Full Text] [Related]
17. Generation of an induced pluripotent stem cell (iPSC) line from a diabetic patient with glucagon receptor (GCGR) p.W83X mutation.
Liu Y; Liu Y; Jia Y; Lv J; Sun D; Yin Y; Liu N; Su B; Sun G
Stem Cell Res; 2022 May; 61():102745. PubMed ID: 35381520
[TBL] [Abstract][Full Text] [Related]
18. Generation of human induced pluripotent stem cell line (XWHNi004-A) from a male with APOE gene mutation.
Wang P; Sun W; Gong J; Han X; Xu C; Chen Y; Yang Y; Luan H; Li S; Li R; Wen B; Lv S; Chen R; Guo J; Wei C
Stem Cell Res; 2024 Jun; 77():103398. PubMed ID: 38552354
[TBL] [Abstract][Full Text] [Related]
19. Generation and characterization of the iPS cell line (SYSUSHi001-A) derived from the peripheral blood mononuclear cells (PBMCs) of a 33-year-old patient with acute myeloid leukemia (AML).
Yuan L; Xie M; Tao Y; Chen X; Xu X; Wang X
Stem Cell Res; 2024 Jun; 77():103360. PubMed ID: 38608356
[TBL] [Abstract][Full Text] [Related]
20. Generation of human induced pluripotent stem cells (EURACi001-A, EURACi002-A, EURACi003-A) from peripheral blood mononuclear cells of three patients carrying mutations in the CAV3 gene.
Meraviglia V; Benzoni P; Landi S; Murano C; Langione M; Motta BM; Baratto S; Silipigni R; Di Segni M; Pramstaller PP; DiFrancesco D; Gazzerro E; Barbuti A; Rossini A
Stem Cell Res; 2018 Mar; 27():25-29. PubMed ID: 29304398
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
